This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Cytomx Therapeutics, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: The Innovations of Rene Hubert
Introduction
Rene Hubert is an accomplished inventor based in South San Francisco, CA. He has made significant contributions to the field of biotechnology, particularly in the development of polypeptides that have specific binding properties.
Latest Patents
Rene Hubert holds a patent for "Single-and Multi-Chain Polypeptides That Bind Specifically to CD3 Epsilon." This innovation showcases his expertise in creating targeted therapeutic agents that can potentially enhance immune responses.
Career Highlights
Rene is currently employed at CytomX Therapeutics, Inc., where he continues to push the boundaries of scientific research and development. His work focuses on advancing therapeutic solutions that can address various medical challenges.
Collaborations
Rene collaborates with talented professionals in his field, including Christopher Kemball and Pia Challita-Eid, who contribute to the innovative environment at CytomX Therapeutics.
Conclusion
Rene Hubert's contributions to biotechnology through his patent and work at CytomX Therapeutics highlight his role as a key innovator in the industry. His efforts in developing specific polypeptides demonstrate the potential for advancements in therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile